- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4439 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
Patent holdings for IPC class A61K 31/4439
Total number of patents in this class: 10984
10-year publication summary
|
636
|
697
|
697
|
681
|
674
|
686
|
614
|
729
|
784
|
187
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10420 |
266 |
| Takeda Pharmaceutical Company Limited | 2726 |
170 |
| Gilead Sciences, Inc. | 2171 |
160 |
| Merck Sharp & Dohme LLC | 3719 |
147 |
| Boehringer Ingelheim International GmbH | 4567 |
138 |
| F. Hoffmann-La Roche AG | 7847 |
125 |
| Bristol-myers Squibb Company | 4821 |
121 |
| AstraZeneca AB | 2832 |
97 |
| Hoffmann-La Roche Inc. | 3659 |
83 |
| Janssen Pharmaceutica N.V. | 3262 |
81 |
| Bayer Pharma AG | 1031 |
77 |
| Vertex Pharmaceuticals Incorporated | 1606 |
76 |
| The Regents of the University of California | 20502 |
74 |
| Pfizer Inc. | 3389 |
70 |
| Axsome Therapeutics, Inc. | 323 |
69 |
| Daiichi Sankyo Company, Limited | 1887 |
67 |
| Eli Lilly and Company | 4016 |
63 |
| Shionogi & Co., Ltd. | 830 |
54 |
| Genentech, Inc. | 4065 |
52 |
| Centre National de La Recherche Scientifique | 10856 |
52 |
| Other owners | 8942 |